Processa Pharmaceuticals Skyrockets on Game-Changing Gastroparesis Deal
Alright, folks, let’s talk about a stock that’s lighting up the market today—Processa Pharmaceuticals (Nasdaq: PCSA). As of this writing, PCSA is up a jaw-dropping 150% in pre-market trading, and it’s all thanks to a blockbuster announcement that’s got investors...